PELAGE PHARMACEUTICALS, INC.

Profile

Company Names

PELAGE PHARMACEUTICALS, INC.

Addresses

907 WESTWOOD BLVD #384, LOS ANGELES, CA 90024

Phone Numbers

949-244-9904

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$150,749,975.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-09-18 
$119,999,987.00 
$119,999,987.00 
$0.00 
Equity 
2
2024-08-12 
$13,999,994.00 
$13,999,994.00 
$0.00 
Equity 
1
2023-06-20 
$16,749,994.00 
$16,749,994.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HEATHER 
 
CHRISTOFK 
EXECUTIVE OFFICER
PELAGE PHARMACEUTICALS, INC.
CATHY 
 
FRIEDMAN 
DIRECTOR
PELAGE PHARMACEUTICALS, INC.   |  PEOPLEONE HEALTH, INC.
DANIEL 
 
GIL 
EXECUTIVE OFFICER, DIRECTOR
PELAGE PHARMACEUTICALS, INC.
RICHARD 
 
HEYMAN 
DIRECTOR
METACRINE, INC.   |  YUMANITY HOLDINGS, LLC   |  VIVIDION THERAPEUTICS, INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  ORIC PHARMACEUTICALS, INC.   |  ENLIVEN THERAPEUTICS, INC.   |  PELAGE PHARMACEUTICALS, INC.
WILLIAM 
EDWARD 
LOWRY 
DIRECTOR, EXECUTIVE OFFICER
PELAGE PHARMACEUTICALS, INC.
CHRISTINA 
 
WENG 
EXECUTIVE OFFICER
PELAGE PHARMACEUTICALS, INC.
NATHAN 
 
WHEELER 
EXECUTIVE OFFICER
PELAGE PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-11-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-18 
2024-08-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-08-12 
2023-06-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#